{"protocolSection": {"identificationModule": {"nctId": "NCT00943397", "orgStudyIdInfo": {"id": "0476-232"}, "secondaryIdInfos": [{"id": "MK0476-232"}, {"id": "2009_619"}], "organization": {"fullName": "Organon and Co", "class": "INDUSTRY"}, "briefTitle": "Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)", "officialTitle": "A Multicenter, Open-Label, Controlled, Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma"}, "statusModule": {"statusVerifiedDate": "2022-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2001-04"}, "primaryCompletionDateStruct": {"date": "2001-10", "type": "ACTUAL"}, "completionDateStruct": {"date": "2001-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2009-07-21", "studyFirstSubmitQcDate": "2009-07-21", "studyFirstPostDateStruct": {"date": "2009-07-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-07-27", "resultsFirstSubmitQcDate": "2010-05-18", "resultsFirstPostDateStruct": {"date": "2010-06-17", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2022-02-01", "lastUpdatePostDateStruct": {"date": "2022-02-03", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Organon and Co", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "Patients were treated with either montelukast 4 mg oral granules or usual care. Patients who completed Protocol MK0476-176-01 (NCT00943683) had the option to enroll in this study. Additionally, patients with asthma who were 6 to 11 months of age and who had not participated in Protocol MK0476-176-01, could also enroll."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 190, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "1", "type": "EXPERIMENTAL", "description": "Montelukast", "interventionNames": ["Drug: montelukast sodium"]}, {"label": "2", "type": "ACTIVE_COMPARATOR", "description": "Usual Care", "interventionNames": ["Drug: Comparator: Usual Care"]}], "interventions": [{"type": "DRUG", "name": "montelukast sodium", "description": "Montelukast 4 mg oral granules mixed with 1 tablespoon soft food once daily at bedtime for 52 weeks", "armGroupLabels": ["1"], "otherNames": ["Montelukast"]}, {"type": "DRUG", "name": "Comparator: Usual Care", "description": "Usual care defined as inhaled/nebulized cromolyn or inhaled nedocromil or inhaled/nebulized corticosteroids, according to the investigator's usual clinical practice for 52 weeks", "armGroupLabels": ["2"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Clinical Adverse Experiences (CAEs) Reported by Patients With up to 52 Weeks of Treatment", "description": "An adverse experience (AE) is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the SPONSOR'S product, whether or not considered related to the use of the product", "timeFrame": "Up to 52 weeks of treatment"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient successfully completed visit 5 of MK0476 Protocol 176 (NCT00943683)\n\nOR:\n\n* Patient is in good, stable health\n* Patient has been fed solid foods for at least 1 month\n* Patients had at least 3 episodes of asthma or asthma-like symptoms, all occurring after 8 weeks of age; at least one within 6 months of the Prestudy Visit\n* Patients had to be in need of a controller therapy according to criteria established in the Global Initiative for Asthma (GINA) guidelines\n\nExclusion Criteria:\n\n* Patient was hospitalized at the start of the study or had any major surgery 4 weeks prior\n* Patient had an allergy to apples or applesauce", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Months", "maximumAge": "2 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Medical Monitor", "affiliation": "Merck Sharp & Dohme LLC", "role": "STUDY_DIRECTOR"}]}, "referencesModule": {"references": [{"pmid": "19449366", "type": "RESULT", "citation": "Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, Knorr B, Noonan G. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol. 2009 Jun;44(6):568-79. doi: 10.1002/ppul.21018."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "This was an open-label, controlled extended safety study. Patients were treated with either montelukast 4-mg oral granules or usual care. Patients who completed Protocol 176-01 had the option to enroll in this study. Additionally, patients with asthma who were 6 to 11 months of age and who had not participated in Protocol 176-01, could also enroll.", "recruitmentDetails": "Patients were recruited at 27 sites in Africa, Europe, North America, and South America Therapy period: May 2001 to Mar 2003.", "groups": [{"id": "FG000", "title": "Usual Care", "description": "Usual care: defined as inhaled/nebulized cromolyn or inhaled nedocromil or inhaled/nebulized corticosteroids, according to the investigator's usual clinical practice for 52 weeks"}, {"id": "FG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with 1 tablespoon soft food once daily at bedtime for 52 weeks."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "32"}, {"groupId": "FG001", "numSubjects": "158"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "Site terminated - Merck administrative decision (11); Discontinued for other (1)", "numSubjects": "17"}, {"groupId": "FG001", "comment": "Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)", "numSubjects": "86"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "72"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Site terminated and other", "reasons": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "56"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Usual Care", "description": "Usual care: defined as inhaled/nebulized cromolyn or inhaled nedocromil or inhaled/nebulized corticosteroids, according to the investigator's usual clinical practice for 52 weeks"}, {"id": "BG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with 1 tablespoon soft food once daily at bedtime for 52 weeks."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "32"}, {"groupId": "BG001", "value": "158"}, {"groupId": "BG002", "value": "190"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Months", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "16.69", "spread": "7.22"}, {"groupId": "BG001", "value": "16.45", "spread": "7.41"}, {"groupId": "BG002", "value": "16.49", "spread": "7.36"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "11"}, {"groupId": "BG001", "value": "45"}, {"groupId": "BG002", "value": "56"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "113"}, {"groupId": "BG002", "value": "134"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Clinical Adverse Experiences (CAEs) Reported by Patients With up to 52 Weeks of Treatment", "description": "An adverse experience (AE) is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the SPONSOR'S product, whether or not considered related to the use of the product", "populationDescription": "All patients who took study medication were included in the analysis.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "Up to 52 weeks of treatment", "groups": [{"id": "OG000", "title": "Usual Care", "description": "Usual care: defined as inhaled/nebulized cromolyn or inhaled nedocromil or inhaled/nebulized corticosteroids, according to the investigator's usual clinical practice for 52 weeks"}, {"id": "OG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with 1 tablespoon soft food once daily at bedtime for 52 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "32"}, {"groupId": "OG001", "value": "158"}]}], "classes": [{"title": "With CAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "156"}]}]}, {"title": "Without CAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Over 52 weeks of treatment and including 14 days follow-up post-treatment AE", "eventGroups": [{"id": "EG000", "title": "Usual Care", "description": "Usual care: defined as inhaled/nebulized cromolyn or inhaled nedocromil or inhaled/nebulized corticosteroids, according to the investigator's usual clinical practice for 52 weeks", "seriousNumAffected": 1, "seriousNumAtRisk": 32, "otherNumAffected": 30, "otherNumAtRisk": 32}, {"id": "EG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with 1 tablespoon soft food once daily at bedtime for 52 weeks.", "seriousNumAffected": 15, "seriousNumAtRisk": 158, "otherNumAffected": 155, "otherNumAtRisk": 158}], "seriousEvents": [{"term": "Bacterial Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 158}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 158}]}, {"term": "Enteritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Gastroenteritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Parotitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Laryngitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 158}]}, {"term": "Pharyngitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Tonsillar Disorder", "organSystem": "General disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 158}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Seizure", "organSystem": "Nervous system disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 158}]}, {"term": "Bronchitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Laryngotracheitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 158}]}], "otherEvents": [{"term": "Bacterial Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 158}]}, {"term": "Fever", "organSystem": "General disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 26, "numAtRisk": 158}]}, {"term": "Influenza-Like Disease", "organSystem": "General disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 20, "numAtRisk": 158}]}, {"term": "Upper Respiratory Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 15, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 82, "numAtRisk": 158}]}, {"term": "Viral Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 17, "numAtRisk": 158}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 30, "numAtRisk": 158}]}, {"term": "Gastroenteritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 158}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 158}]}, {"term": "Allergic Rhinitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 19, "numAtRisk": 158}]}, {"term": "Conjunctivitis", "organSystem": "Eye disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 158}]}, {"term": "Nasopharyngeal Disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 158}]}, {"term": "Otitis", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Otitis Media", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 39, "numAtRisk": 158}]}, {"term": "Pharyngitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 14, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 58, "numAtRisk": 158}]}, {"term": "Rhinitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 18, "numAtRisk": 158}]}, {"term": "Sinusitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 158}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 158}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 18, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 77, "numAtRisk": 158}]}, {"term": "Bronchitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 158}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 158}]}, {"term": "Respiratory Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 158}]}, {"term": "Contact Dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 158}]}, {"term": "Cutaneous Candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 158}]}, {"term": "Eczematous Dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 158}]}, {"term": "Varicella", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionary", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 32}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 158}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."}, "pointOfContact": {"title": "Senior Vice President, Global Clinical Development", "organization": "Merck Sharp & Dohme Corp", "phone": "1-800-672-6372"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000093875", "term": "Montelukast"}], "ancestors": [{"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000020024", "term": "Leukotriene Antagonists"}, {"id": "D000006727", "term": "Hormone Antagonists"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000065694", "term": "Cytochrome P-450 CYP1A2 Inducers"}, {"id": "D000065693", "term": "Cytochrome P-450 Enzyme Inducers"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M274108", "name": "Montelukast", "asFound": "Means", "relevance": "HIGH"}, {"id": "M7386", "name": "Cromolyn Sodium", "relevance": "LOW"}, {"id": "M20024", "name": "Nedocromil", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M21876", "name": "Leukotriene Antagonists", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}]}}, "hasResults": true}